Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gene therapy
Pharma
Novartis peels back Zolgensma IT data in older SMA patients
Two data sets indicate the potential for intrathecal Zolgensma to be a meaningful treatment option for older patients with SMA, Novartis argues.
Angus Liu
Mar 19, 2025 9:00am
Patient dies after receiving Sarepta's DMD gene therapy Elevidys
Mar 18, 2025 10:34am
$2.4B gene therapy impairment sparks Roche restructure
Mar 10, 2025 3:15pm
Once valued at $10B, struggling bluebird bio sold for $29M
Feb 21, 2025 10:56am
Pfizer empties gene therapy portfolio, discontinuing Beqvez
Feb 21, 2025 10:48am
Orchard names commercial chief for world’s most expensive drug
Feb 12, 2025 11:40am
